CHAUDHARY MANU has a total of 32 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and environmental technology are OREXO AB, SEANERGY DERMATOLOGY LTD and ZHU LINGXIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | Mexico | 2 | |
#7 | South Africa | 2 | |
#8 | Brazil | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 | |
#11 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Chaudhary Manu | 32 |
#2 | Naithani Vijay | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020208395A1 | Oral herbal pain killer formulations | |
CA2962540A1 | Stealth, targeted nanoparticles (stn) for oral drug delivery | |
WO2013042140A2 | Non antibiotic, non peptide compounds for antibiotic efficacy & safety enhancement | |
WO2012156999A1 | Ready to use docetaxel formulation | |
US2013136798A1 | Parenteral controlled release formulations of NSAID's | |
AU2011322066A1 | A detoxifier herbal formulation | |
EP2334298A2 | Novel single unit carbapenem aminoglycoside formulations |